Skip to main content
INGR logo

INGR · Ingredion Inc

Track INGR — free
$95.81 -0.65 (-0.67%) At close · Sep 30
Market Cap
$6.10B
Shares
63.06M
Volume · Sep 30 626.12K Avg daily vol (3M) 655.45K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$95.81 Open$96.55 Day$95.62–97.06 52W close$94.71–122.11 Avg vol 30d611K Short int4.5M · 7.2% float · 7.2d Short vol54% Last earningsAug 4, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 5 wks
filed Aug 7, 2026
call held Aug 4, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$7.21B
Trailing 12 months
Net income (TTM)
$592.00M
Trailing 12 months
Revenue growth YoY
+0.9%
Year over year
Operating margin
11.9%
Trailing 12 months
P / E (TTM)
10.5
Trailing earnings · reciprocal yield 9.5%
FCF yield
5.8%
TTM · current market cap
Return on invested capital
11.8%
Trailing 12 months
Net cash
−$835.00M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.6%
Year over year · fewer shares
Price change (1Y)
-20.4%
Trailing year
Short interest
7.2%
Latest settlement · 7.2 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Aug 4, 2026
Q2 FY26

TL;DR. Ingredion's Q2 net sales rose 1% to $1.85B while adjusted operating income fell 5% to $258M; the company reaffirmed full-year 2026 adjusted EPS guidance of $10.30-$10.90 (after amending for the Pakistan sale) and announced that Tate & Lyle shareholders approved the acquisition.

Bullish
  • + Tate & Lyle shareholders approved the all-cash acquisition, a key milestone toward closing the transformational deal.
  • + Texture & Healthful Solutions delivered its ninth consecutive quarter of net sales volume growth, up 7%, with second-highest segment operating income ever.
  • + Argo plant reliability improved sequentially and was operating at normal production rates across all major operating units by end of June.
  • + Full-year 2026 adjusted EPS guidance of $10.30 to $10.90 was reaffirmed after amending for the Pakistan sale.
  • + Pending Tate & Lyle deal expected to add $2.7B of revenue, deliver $130M of run-rate synergies by 2030, and provide greater than 15% adjusted EPS accretion in the first full year post-close.
Bearish
  • − Q2 adjusted operating income fell 5% and adjusted EPS declined $0.05 year-over-year, driven by Argo issues and Mexico headwinds.
  • − Full-year 2026 adjusted operating income is now expected to be down mid-single digits (previously down low single digits) due to the Pakistan sale amendment.
  • − Tapioca costs surged more than 40% year-to-date due to weather-related supply impacts, creating near-term margin pressure.
  • − Net financing costs jumped to $55M in Q2 from $12M a year ago, driven by a $47M mark-to-market FX loss on Tate & Lyle-related hedging.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very Low
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg −6%
below
RSI (14) 31
neutral
MACD trend Negative
52-week position 4%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −8%
trailing
6-month return −17%
trailing
YTD return −13%
this year
Relative strength −29%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $102 › 200d $107 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +77 funds added
Insider flow Distributing
Net -$170.0K over 90 days · 100% sells
Short interest Rising
7.16% of float · ▲ +7.6% MoM · 7.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
614 holders — mid 3-yr range
Squeeze score 69
elevated · 0–100
Fundamentals
Strong
Revenue growth −3%
Y/Y
Gross margin 25%
expanding
EPS growth +15%
Y/Y
Free cash flow $511.0M
Valuation P/E 10.6
below peers
Balance sheet $1.4B
net debt
Quant / Vol
risk profile
Very Low
Volatility 18%
annualized · 1-yr
Max drawdown −22%
past year
ATR 1.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 1 of last 2
Latest guidance · from the Earnings Call filed Aug 4, 2026
Adjusted earnings per share · full year 2026 Non-GAAP Initiated $10.30 – $10.90
Capital expenditures · full year 2026 Initiated $450M – $490M
Guided vs delivered · last 2 settled
Reported EPS full-year 2024
guided $10.20 – $10.70
$9.71 Miss −7.1%
GAAP EPS Full-Year 2023
guided $9.25 – $9.65
$9.60 In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
−6% Bearish
RSI (14)
31 Neutral
MACD trend
Negative Bearish
52-week position
4% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $102 › 200d $107 — 200d above 50d
Institutional flow Distributing
-8% holders QoQ · +77 funds added
Insider flow Distributing
Net -$170.0K over 90 days · 100% sells
Short interest Rising
7.16% of float · ▲ +7.6% MoM · 7.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
614 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $95 Now $96 · 4% Range high $122
vs 200-day avg -11% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
All Other net sales $124M the second quarter of 2026 filing —
All Other operating income $6M the second quarter of 2026 filing —
F&II–LATAM net sales $611M the second quarter of 2026 filing —
F&II–LATAM operating income $118M the second quarter of 2026 filing —
F&II–U.S./Canada net sales $488M the second quarter of 2026 filing —
F&II–U.S./Canada operating income $58M the second quarter of 2026 filing —
T&HS net sales $627M the second quarter of 2026 filing —
T&HS operating income $117M the second quarter of 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Packaged Foods — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
INGR
Ingredion Inc
this stock
$6.10B -13.1% -2.8% 10.6 7.2%
JBS
Jbs N.V.
$38.06B -21.7% — — 1.2%
KHC
Kraft Heinz Co
$28.02B -6.3% -0.1% — 7.9%
GIS
General Mills Inc
$17.99B -30.8% +4.1% — 8.4%
SJM
J M SMUCKER Co
$12.93B +21.6% +3.7% — 4.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
614
% held
98.9%
Net QoQ
+94.8K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
477
View
Short & Settlement
Short Interest Rising
Shares short
4.5M
Days to cover
7.2d
Change
+319.3K sh
View
Short Volume
Short vol %
54%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
1.9K
Value
$203.4K
As of
Aug 27, 2026
View
Off-Exchange
Off-exchange %
41.1%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$170.0K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Lisa McClain
Amount
$1.0K–$15.0K
Traded
Oct 14, 2025
View
Financials
Financials
Revenue (FY)
$7.2B
Net income (FY)
$729.0M
EPS diluted
$11.18
View
Buybacks
Authorized
shares 8.0M
Remaining
shares 7.3M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 20, 2026
This year
22
View
Proposed Sales
Value
$170.0K
Shares
1.7K
Filed
Aug 5, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 4, 2026
View

Performance

5D 20D 120D MTD YTD
INGR -1.0% -8.1% -16.6% -7.4% -13.1%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -0.4% -8.2% -28.8% -6.8% -25.0%

Capital returns

Latest dividend
$0.83 / share · ex Oct 1, 2026
Paid (TTM)
$0.83 / share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Buyback program · as of Jun 30, 2026
Authorized
shares 8.00M
Spent (derived)
shares 700,000
Remaining
shares 7.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1046257 CUSIP 457187102 13F (30d) 12 filings 11 filers Visit website Investor relations